Transarterial chemoembolization (TACE) plus sorafenib versus TACE for intermediate or advanced stage hepatocellular carcinoma: a meta-analysis
about
Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocolsTransarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patientsTreatment of hepatocellular carcinoma: Steps forward but still a long way to goRecommendations for the use of chemoembolization in patients with hepatocellular carcinoma: Usefulness of scoring system?Current systemic treatment of hepatocellular carcinoma: A review of the literatureCombination treatment including targeted therapy for advanced hepatocellular carcinomaEvaluation of the Efficacy of Sorafenib on Overall Survival in Patients with Hepatocellular Carcinoma using FT Rate: A Devised IndexSorafenib and 2,3,5-triiodobenzoic acid-loaded imageable microspheres for transarterial embolization of a liver tumorEfficacy and safety of TACE in combination with sorafenib for the treatment of TACE-refractory advanced hepatocellular carcinoma in Chinese patients: a retrospective study.Evolving role of Sorafenib in the management of hepatocellular carcinoma.Intermediate hepatocellular carcinoma: How to choose the best treatment modality?Pharmacokinetic study of conventional sorafenib chemoembolization in a rabbit VX2 liver tumor model.Skeletal muscle depletion predicts the prognosis of patients with hepatocellular carcinoma treated with sorafenibSorafenib combined with transarterial chemoembolization in patients with hepatocellular carcinoma: a meta-analysis and systematic review.Management of hepatocellular carcinoma: an overview of major findings from meta-analysesImaging Intratumoral Nanoparticle Uptake After Combining Nanoembolization with Various Ablative Therapies in Hepatic VX2 Rabbit Tumors.Thalidomide combined with transcatheter artierial chemoembolzation for primary hepatocellular carcinoma: a systematic review and meta-analysis.Adjuvant sorafenib after heptectomy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma patients.Modified transarterial chemoembolization with locoregional administration of sorafenib for treating hepatocellular carcinoma: feasibility, efficacy, and safety in the VX-2 rabbit liver tumor modelHepatocellular carcinoma: systemic therapies and future perspectives.Review of preoperative transarterial chemoembolization for resectable hepatocellular carcinoma.Diagnosis and treatment of hepatocellular carcinoma: An update.Current management of hepatocellular carcinoma: an Eastern perspective.Preparation and structure of drug-carrying biodegradable microspheres designed for transarterial chemoembolization therapy.Early treatment response to transcatheter arterial chemoembolization is associated with time to the development of extrahepatic metastasis and overall survival in intermediate-stage hepatocellular carcinoma.Treatment of Advanced Hepatocellular Carcinoma after Failure of Sorafenib Treatment: Subsequent or Additional Treatment Interventions Contribute to Prolonged Survival Postprogression.The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma.Advances and Future Directions in the Treatment of Hepatocellular CarcinomaA Surgical Perspective on Targeted Therapy of Hepatocellular Carcinoma.Comparative effectiveness of different transarterial embolization therapies alone or in combination with local ablative or adjuvant systemic treatments for unresectable hepatocellular carcinoma: A network meta-analysis of randomized controlled trialCost-effectiveness analysis of treatment with non-curative or palliative intent for hepatocellular carcinoma in the real-world setting.Hepatocellular carcinoma developed in a living donor after left lobe donation: a case for caution.Microwave ablation versus transarterial chemoembolization in large hepatocellular carcinoma: prospective analysis.Transcatheter arterial chemoembolization plus sorafenib versus transcatheter arterial chemoembolization alone to treat advanced hepatocellular carcinoma: a meta-analysis.Sorafenib improves lipiodol deposition in transarterial chemoembolization of Chinese patients with hepatocellular carcinoma: a long-term, retrospective study.Surgery for advanced hepatocellular carcinoma: Time to take action.Anti-tumor Effects of Sorafenib Administered at Different Time Points in Combination with Transarterial Embolization in a Rabbit VX2 Liver Tumor Model.Patient Selection for Transarterial Chemoembolization in Hepatocellular Carcinoma: Importance of Benefit/Risk Assessment.Transarterial Chemoembolization within First 3 Months of Sorafenib Initiation Improves Overall Survival in Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study with Propensity Matching.Effect of curcumin on vascular endothelial growth factor in hypoxic HepG2 cells via the insulin-like growth factor 1 receptor signaling pathway.
P2860
Q26783881-799BF161-4B62-4BCF-ABC2-B3604E690BC1Q26799469-F4F38B72-E809-4631-A81C-F783C6F52C0AQ26865456-64DCE409-815C-4B50-96CD-9A232FBD6B77Q27022015-062AF39E-C6F4-4C48-99BB-1184EEFDC425Q27026036-213F76B3-AA4D-4224-8F1A-3D52C54AE5A4Q28077738-FE8FE41C-8A69-4B12-894E-E51FEF489E0BQ33665679-074181A7-53D4-49B6-82E3-45A5D350DBAEQ33677699-AC603C43-1699-4065-8D51-33120A263736Q33758258-294FD80A-AE95-407D-B0E2-200C6C3C2A7BQ33779864-B8C5DB46-EBB6-4ACC-8C1E-7472B780720CQ35626764-5A35CFDE-82E7-4A67-A255-30BC1F74360DQ35720473-B6F1FC8B-660E-4572-9353-67FA806BFA0FQ35722941-01FE9D63-3EB9-4D3D-9FCA-A9AD4B5E14A8Q35917459-0E5578C2-DC69-4741-ABDE-F38DF0B488F8Q36014255-44D3B182-F68B-44A0-A3F7-F0087D104FEDQ36053235-22263205-EE89-4EEA-897D-1262B16C8661Q36344688-32C4FE7B-6668-4FD0-8EC2-93CE13000B21Q37012378-E639662D-C351-4400-8AD8-96F408818969Q37114870-2EBB5114-4D30-4FF4-BE58-FD390995AD3CQ38246965-6768D232-8EA4-41E3-B96E-CBCF01565286Q38334020-9FF3C838-3677-4E8C-83CE-A39FB7C6317BQ38408866-465271F3-C08E-4C15-A4BB-72A0A666A469Q38410816-F9791C93-970A-4CC8-A800-E3009598DB5BQ38937729-CF2832BA-912F-4758-859C-40261264300FQ40443863-EB47C155-A9B0-47EA-8D73-C6FC4295E2FBQ40955279-D0587E75-8868-4B83-98C2-22F733A47B1CQ41172447-52CF1A71-2D64-4D6C-B67C-288627627369Q41531360-0598656D-166D-44CB-95B1-8CD7C732A4B2Q42064611-C50EAEB8-8053-47F2-BD2B-AD7BBA33D84CQ42362049-16A4A425-157A-4819-B447-F5789ED095C5Q42706768-9744C398-9A4B-4A0C-B922-048B2B0C55A2Q44479439-41676EE6-0EA4-4CEE-B418-79D711850B1AQ46950107-12BAEF23-B3D3-462B-87A9-5BD0B249AC2FQ47158378-C07EAEE1-7FBA-4881-BF52-985C1BB0EBC0Q47160108-091780D4-7D6E-4B83-8F90-FA5EF3C41DF8Q48066360-66FAA05A-8516-488E-A79F-600288402B0BQ48309588-8D71E0EA-B8FE-42F1-898C-9C6B4B68F274Q52584231-7046D771-8A2E-473C-8CE9-0011C53237F4Q52686882-6DDAC918-755B-4ADF-AB53-7A013D4A68AFQ54118581-E30DC246-AED4-44EE-A0B6-3D83A0AEE7DE
P2860
Transarterial chemoembolization (TACE) plus sorafenib versus TACE for intermediate or advanced stage hepatocellular carcinoma: a meta-analysis
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Transarterial chemoembolizatio ...... lar carcinoma: a meta-analysis
@ast
Transarterial chemoembolizatio ...... lar carcinoma: a meta-analysis
@en
type
label
Transarterial chemoembolizatio ...... lar carcinoma: a meta-analysis
@ast
Transarterial chemoembolizatio ...... lar carcinoma: a meta-analysis
@en
prefLabel
Transarterial chemoembolizatio ...... lar carcinoma: a meta-analysis
@ast
Transarterial chemoembolizatio ...... lar carcinoma: a meta-analysis
@en
P2093
P2860
P1433
P1476
Transarterial chemoembolizatio ...... lar carcinoma: a meta-analysis
@en
P2093
P2860
P304
P356
10.1371/JOURNAL.PONE.0100305
P407
P577
2014-06-19T00:00:00Z